Rosenfeld R G, Ceda G, Wilson D M, Dollar L A, Hoffman A R
Endocrinology. 1984 May;114(5):1571-5. doi: 10.1210/endo-114-5-1571.
Primary cultures of rat anterior pituitary cells were assessed for the presence of specific receptors for insulin and for the somatomedin peptides, insulin-like growth factors I and II (IGF-I and IGF-II). Specific binding per 100,000 pituitary cells averaged 9.45 +/- 1.69% (mean +/- SD) for [125I]IGF-II, 0.83 +/- 0.06% for [125I]IGF-I, and only 0.11% for [125I]insulin, IGF-II was twice as potent as IGF-I in displacing [125I]IGF-II, while insulin was totally nonreactive, IGF-I was 5-fold more potent than IGF-II at displacing [125I]IGF-I and 1000-fold more potent than insulin. Scatchard analysis of [125I]IGF-II binding revealed a curvilinear plot, which could be resolved into a high affinity receptor with a Ka of 7.0 X 10(8) M-1 and 120,000 receptor sites/cell, and a low affinity receptor with a Ka of 1.1 X 10(8) M-1 and 720,000 receptor sites/cell. The existence of abundant high affinity somatomedin receptors (especially for IGF-II) on rat anterior pituitary cells is consistent with a potential role for these peptides in the regulation of GH secretion.
对大鼠垂体前叶细胞的原代培养物进行评估,以检测胰岛素和生长调节素肽(胰岛素样生长因子I和II,即IGF-I和IGF-II)的特异性受体。每100,000个垂体细胞对[125I]IGF-II的特异性结合平均为9.45±1.69%(平均值±标准差),对[125I]IGF-I的特异性结合为0.83±0.06%,而对[125I]胰岛素的特异性结合仅为0.11%。在置换[125I]IGF-II方面,IGF-II的效力是IGF-I的两倍,而胰岛素则完全无反应。在置换[125I]IGF-I方面,IGF-I的效力比IGF-II高5倍,比胰岛素高1000倍。对[125I]IGF-II结合的Scatchard分析显示为曲线,可解析为一个高亲和力受体,其Ka为7.0×10(8) M-1,每个细胞有120,000个受体位点,以及一个低亲和力受体,其Ka为1.1×10(8) M-1,每个细胞有720,000个受体位点。大鼠垂体前叶细胞上存在丰富的高亲和力生长调节素受体(特别是对IGF-II),这与这些肽在调节生长激素分泌中的潜在作用一致。